Verition Fund Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84M Buy
3,200
+2,900
+967% +$2.96M 0.02% 782
2026
Q1
$276K Buy
+300
New +$304K ﹤0.01% 1811
2025
Q4
Sell
-225,300
Closed -$172M 3746
2025
Q3
$172M Buy
225,300
+224,700
+37,450% +$167M 0.71% 10
2025
Q2
$468K Sell
600
-900
-60% -$699K ﹤0.01% 2984
2025
Q1
$1.24M Sell
1,500
-2,500
-63% -$2.08M 0.01% 1953
2024
Q4
$3.09M Buy
4,000
+1,800
+82% +$1.49M 0.01% 1248
2024
Q3
$1.95M Sell
2,200
-7,100
-76% -$6.38M 0.01% 1431
2024
Q2
$8.42M Buy
9,300
+5,800
+166% +$4.64M 0.05% 435
2024
Q1
$2.72M Buy
3,500
+100
+3% +$71.2K 0.02% 1039
2023
Q4
$1.98M Sell
3,400
-8,400
-71% -$4.9M 0.02% 849
2023
Q3
$6.34M Sell
11,800
-53,300
-82% -$27.5M 0.07% 350
2023
Q2
$30.5M Buy
+65,100
New +$27.3M 0.41% 40
2023
Q1
Sell
-12,500
Closed -$4.57M 2384
2022
Q4
$4.57M Sell
12,500
-2,600
-17% -$922K 0.07% 343
2022
Q3
$4.88M Buy
+15,100
New +$4.78M 0.05% 419
2022
Q2
Sell
-20,100
Closed -$5.76M 2751
2022
Q1
$5.76M Buy
20,100
+2,200
+12% +$566K 0.07% 326
2021
Q4
$4.94M Buy
17,900
+8,300
+86% +$2.1M 0.04% 365
2021
Q3
$2.22M Buy
+9,600
New +$2.37M 0.02% 573

Other funds holding LLY

Verition Fund Management's LLY Position: Q2 2026 in Review

Verition Fund Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $365K and bringing the position to 3,365 shares worth $4.04M. The position accounts for 0.02% of the portfolio, ranked #751.

Verition Fund Management first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. The position peaked at $182M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Verition Fund Management held 3,365 shares of Eli Lilly worth $4.04M as of Q2 2026.
  • Verition Fund Management bought 357 Eli Lilly shares in Q2 2026, an estimated $365K.
  • Eli Lilly made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #751 holding.
  • Verition Fund Management first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
  • Verition Fund Management's Eli Lilly position peaked at $182M in Q3 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.